Author

Gabriel L. Fiszman

Consejo Nacional de Investigaciones Científicas y TécnicasORCID 0000-0001-6307-8372Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Carla Pulero· 1 shared Ezequiel LacunzaiD· 1 shared Georgina Alexandra CardamaiD· 1 shared Giorgio ArrigoniiD· 1 shared Giulia RoccaiD· 1 shared Marcela Solange VillaverdeiD· 1 shared Marianela Abrigo· 1 shared Virginia Judith WolosiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carla Pulero

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 9, 2026

Hypoxia drives trastuzumab resistance through Rac1 pathway in HER2-positive breast cancer

Virginia Judith Wolos, Giulia Rocca, Marianela Abrigo…·Gabriel L. Fiszman

This study identifies hypoxia-driven Rac1 pathway activation as a mechanism of trastuzumab resistance in HER2-positive breast cancer and shows Rac1 inhibition can restore drug sensitivity.

DOI 10.64898/2026.05.05.723085

humanproteomics

𝕏 PostBluesky